Φορτώνει......
Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
Imatinib (Gleevec) is a biological agent that is approved for the treatment of chronic myeloid leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most frequently seen adverse effects in patients treated with imatinib include superficial edema, muscle cramps, musculoskeletal pain, r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cureus |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Cureus
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120973/ https://ncbi.nlm.nih.gov/pubmed/27909636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.848 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|